Sunday, March 02, 2025 | 11:05 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

World accepts much-maligned China's Covid-19 vaccine but doubts remain

Sinovac has shipped some 380 million doses, but it still hasn't published any data in an academic journal.

A study of some 128,000 Jakarta health workers released Wednesday found Sinovac’s vaccine was far more protective than clinical trials had indicated.
Premium

A study of some 128,000 Jakarta health workers released Wednesday found Sinovac’s vaccine was far more protective than clinical trials had indicated.

Bloomberg
Indonesia, one of the first nations to bet its Covid-19 vaccination campaign on Sinovac Biotech Ltd., was about to announce a stunning development, one that would help vindicate a shot that’s been shrouded in controversy for months. Over in Beijing, though, the company’s chief executive officer was unaware.
 

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in